ArticleCurrent oncology (Toronto, Ont.)2024
Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer.
Takuma Hayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.